Our results indicated that the treatment suppressed the pro-inflammatory cytokines (TNF-α, IL-6, IL-1β and IL-17A) but up-regulated the anti-inflammatory cytokines (TGF-β1 and IL-10), indicating that the therapeutic effect of TP in RA may simultaneously target various cytokines. Here, IL17A is linked to rheumatoid arthritis.